Trials / Conditions / Candidiasis, Vulvovaginal

Candidiasis, Vulvovaginal

19 registered clinical trials studyying Candidiasis, Vulvovaginal — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence NCT07521137	Sano Chemicals Inc	Phase 2
Recruiting	The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasi NCT05367089	Maastricht University Medical Center	Phase 3
Unknown	A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis NCT05059145	Karolinska Institutet	Phase 2
Recruiting	Vulvovaginal Candidiasis in Canadian Females NCT04930107	University of Manitoba	EARLY_Phase 1
Unknown	Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis NCT04626258	Maastricht University Medical Center	Phase 4
Withdrawn	Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvo NCT03167957	Matinas BioPharma Nanotechnologies, Inc.	Phase 2
Completed	Non-ablative Er:YAG for Recurrent Candidiasis NCT06572488	Espacio Gaspar Clinic	N/A
Unknown	Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Tri NCT03075046	Centro de Atenção ao Assoalho Pélvico	N/A
Completed	Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candid NCT02971007	Matinas BioPharma Nanotechnologies, Inc.	Phase 2
Completed	Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization NCT02888197	Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	—
Terminated	Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis NCT02859493	Lesaffre International	N/A
Completed	RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections NCT02733432	Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Completed	Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis NCT03975569	University Hospital, Antwerp	N/A
Completed	Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillu NCT02730494	Biose	Phase 1
Completed	Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis NCT02180828	Peking University Shenzhen Hospital	Phase 4
Completed	Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regene NCT02251093	Probionov	Phase 3
Completed	A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast NCT01891331	Viamet	Phase 2
Completed	Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis NCT02248506	Instituto Palacios	Phase 4
Completed	A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetrac NCT01293643	Merck Sharp & Dohme LLC	Phase 3